BofA Securities analyst Craig Bijou upgraded Globus Medical (NYSE: GMED) from Underperform to Neutral with a price target of $97.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE